References
- Bateman DN, Eagling V, Sandilands EA, et al. Iron overdose epidemiology, clinical features and iron concentration-effect relationships: the UK experience 2008–2017. Clin Toxicol (Phila). 2018;56:1098–1106.
- Tenenbein M. Hepatotoxicity in acute iron poisoning. J Toxicol Clin Toxicol. 2001;39:721–726.
- Anderson AC. Iron poisoning in children. Curr Opin Pediatr. 1994;6:289–294.
- Schauben JL, Augenstein WL, Cox J, et al. Iron poisoning: report of three cases and a review of therapeutic intervention. J Emerg Med. 1990;8:309–319.
- Tenenbein M. Benefits of parenteral deferoxamine for acute iron poisoning. J Toxicol Clin Toxicol. 1996;34:485–489.
- Geisser P, Burckhardt S. The pharmacokinetics and pharmacodynamics of iron preparations. Pharmaceutics. 2011;3:12–33.
- Wood DM, Thomson AH, Lawes M, et al. Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child. Ther. Drug Monit. 2005;27:405–408.
- Beuhler MC, Wallace KL. Benign outcome with toxic serum iron levels following IV iron dextran overdose in three patients. Clin Toxicol (Phila). 2003;41:738–739.
- Yassin M, Soliman AT, De Sanctis V, et al. A young adult with unintended acute intravenous iron intoxication treated with oral chelation: The use of liver ferriscan for diagnosing and monitoring tissue iron load. Mediterr J Hematol Infect Dis. 2017;9:e2017008.